相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-CTLA-4 antibody-induced Guillain-Barre syndrome in a melanoma patient
S. Wilgenhof et al.
ANNALS OF ONCOLOGY (2011)
Frequency of regulatory T cells in peripheral blood and in tumour-infiltrating lymphocytes correlates with poor prognosis in renal cell carcinoma
Francesco Liotta et al.
BJU INTERNATIONAL (2011)
Suppression of T-cell responses by tumor metabolites
Katrin Singer et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Antigen Spreading Contributes to MAGE Vaccination-Induced Regression of Melanoma Metastases
Veronique Corbiere et al.
CANCER RESEARCH (2011)
Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents
I. Jolanda M. de Vries et al.
CLINICAL CANCER RESEARCH (2011)
Using an Ancient Tool for Igniting and Propagating Immune Tolerance: IDO as an Inducer and Amplifier of Regulatory T Cell Functions
F. Fallarino et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Modulation of human T-cell functions by reactive nitrogen species
Tihana Kasic et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins
Mouldy Sioud et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2011)
Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
Sahar M. A. Mahmoud et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer
Lucia De Monte et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties
Sven Brandau et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis
Howard Trachtman et al.
KIDNEY INTERNATIONAL (2011)
Vitamin D inhibits CEACAM1 to promote insulin/IGF-I receptor signaling without compromising anti-proliferative action
Wei Liu et al.
LABORATORY INVESTIGATION (2011)
Early T Cell Signalling Is Reversibly Altered in PD-1+ T Lymphocytes Infiltrating Human Tumors
Shu-Fang Wang et al.
PLOS ONE (2011)
New Insights into Mesenchymal Stromal Cell-Mediated T-Cell Suppression Through Galectins
M. Sioud
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2011)
Molecular Profiling of Melanoma and the Evolution of Patient-Specific Therapy
Thomas F. Gajewski
SEMINARS IN ONCOLOGY (2011)
Presence of Tumor-infiltrating Lymphocytes and a Dominant Nodule Within Primary Melanoma Are Prognostic Factors for Relapse-Free Survival of Patients With Thick (T4) Primary Melanoma
Uma N. M. Rao et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Ex vivo- and in vivo-induced dead tumor cells as modulators of antitumor responses
Eva-Maria Weiss et al.
CLEARANCE OF DYING CELLS IN HEALTHY AND DISEASED IMMUNE SYSTEMS (2010)
GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death
Matthew J. Streetly et al.
BLOOD (2010)
Diagnostic and prognostic value of serum nitric oxide, tumor necrosis factor-alpha, basic fibroblast growth factor and copper as angiogenic markers in premenopausal breast cancer patients: a case-control study
T. I. Hewala et al.
BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2010)
A Galectin-3 Ligand Corrects the Impaired Function of Human CD4 and CD8 Tumor-Infiltrating Lymphocytes and Favors Tumor Rejection in Mice
Nathalie Demotte et al.
CANCER RESEARCH (2010)
Phase II Trial of Tremelimumab (CP-675,206) in Patients with Advanced Refractory or Relapsed Melanoma
John M. Kirkwood et al.
CLINICAL CANCER RESEARCH (2010)
Tremelimumab in Combination with Exemestane in Patients with Advanced Breast Cancer and Treatment-Associated Modulation of Inducible Costimulator Expression on Patient T Cells
Robert H. Vonderheide et al.
CLINICAL CANCER RESEARCH (2010)
Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients
Joannes F. M. Jacobs et al.
CLINICAL CANCER RESEARCH (2010)
Significance of Preoperative Evaluations of Tumor Necrosis Factor-Alpha, the Granulocyte/Lymphocyte Ratio and Their Correlation with Regard to Outcome in Gastric Cancer Patients
Hideyuki Ubukata et al.
DIGESTIVE SURGERY (2010)
Modulated expression of adhesion molecules and galectin-1: Role during mesenchymal stromal cell immunoregulatory functions
Mehdi Najar et al.
EXPERIMENTAL HEMATOLOGY (2010)
Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds
Tiziana Di Pucchio et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Biomolecular Network Reconstruction Identifies T-Cell Homing Factors Associated With Survival in Colorectal Cancer
Bernhard Mlecnik et al.
GASTROENTEROLOGY (2010)
Spatiotemporal Basis of CTLA-4 Costimulatory Molecule-Mediated Negative Regulation of T Cell Activation
Tadashi Yokosuka et al.
IMMUNITY (2010)
Generation and Accumulation of Immunosuppressive Adenosine by Human CD4+CD25highFOXP3+ Regulatory T Cells
Magis Mandapathil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
N- and O-Glycans Modulate Galectin-1 Binding, CD45 Signaling, and T Cell Death
Lesley A. Earl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Higher intratumoral infiltrated Foxp3+Treg numbers and Foxp3+/CD8+ratio are associated with adverse prognosis in resectable gastric cancer
Zhengbin Shen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
BTLA mediates inhibition of human tumor-specific CD8(+) T cells that can be partially reversed by vaccination
Laurent Derre et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity
Rachel H. McMahan et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Phase II Study of the Anti-Cytotoxic T-Lymphocyte-Associated Antigen 4 Monoclonal Antibody, Tremelimumab, in Patients With Refractory Metastatic Colorectal Cancer
Ki Y. Chung et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients
Julien Fourcade et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients
Valerie Chew et al.
JOURNAL OF HEPATOLOGY (2010)
Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Richard E. Royal et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Rational Design of Indoleamine 2,3-Dioxygenase Inhibitors
Ute F. Roehrig et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways
Yi-Lan Zhang et al.
MOLECULAR CANCER (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Immune infiltration in human tumors: a prognostic factor that should not be ignored
F. Pages et al.
ONCOGENE (2010)
Tumor-infiltrating lymphocytes, particularly the balance between CD8+ T cells and CCR4+ regulatory T cells, affect the survival of patients with oral squamous cell carcinoma
Yoshiko Watanabe et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2010)
Evidence for the Involvement of Galectin-3 in Mesenchymal Stem Cell Suppression of Allogeneic T-Cell Proliferation
M. Sioud et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2010)
Anti-CTLA-4 Antibody Therapy: Immune Monitoring During Clinical Development of a Novel Immunotherapy
Margaret K. Callahan et al.
SEMINARS IN ONCOLOGY (2010)
FOXP3+ regulatory T cells in the human immune system
Shimon Sakaguchi et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Infiltrating CTLs in Human Glioblastoma Establish Immunological Synapses with Tumorigenic Cells
Carlos Barcia et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
T Cell Infiltrate Predicts Long-Term Survival Following Resection of Colorectal Cancer Liver Metastases
Steven C. Katz et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Clinical Significance of Tumor-Infiltrating Lymphocytes in Lung Neoplasms
Enrico Ruffini et al.
ANNALS OF THORACIC SURGERY (2009)
Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells
Jihene Klibi et al.
BLOOD (2009)
Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy
Alan G. Ramsay et al.
BLOOD (2009)
Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells
David J. Chung et al.
BLOOD (2009)
Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts
Rifca Le Dieu et al.
BLOOD (2009)
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
Mojgan Ahmadzadeh et al.
BLOOD (2009)
Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma
Dominik Pretscher et al.
BMC CANCER (2009)
Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia
Matthias Haas et al.
BMC GASTROENTEROLOGY (2009)
Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes
M. Stumpf et al.
BRITISH JOURNAL OF CANCER (2009)
Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: immunoadhesins for human IL-10 with therapeutic potential
Mizue Terai et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
The CD4+ T-Cell Response of Melanoma Patients to a MAGE-A3 Peptide Vaccine Involves Potential Regulatory T Cells
Violaine Francois et al.
CANCER RESEARCH (2009)
Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase-Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer
Feng Qian et al.
CANCER RESEARCH (2009)
Arginase I-Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes
Paulo C. Rodriguez et al.
CANCER RESEARCH (2009)
Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival
Jonathan R. Brody et al.
CELL CYCLE (2009)
Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: Outcome analysis from a single-institution prospectively collected database
M. Mandala et al.
EUROPEAN JOURNAL OF CANCER (2009)
Comparison of stable human Treg and Th clones by transcriptional profiling
Julie Stockis et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines
William D. Hastings et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Recognition of galactan components of pectin by galectin-3
A. Patrick Gunning et al.
FASEB JOURNAL (2009)
The α-galactomannan Davanat binds galectin-1 at a site different from the conventional galectin carbohydrate binding domain
Michelle C. Miller et al.
GLYCOBIOLOGY (2009)
Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer
R. A. de Jong et al.
GYNECOLOGIC ONCOLOGY (2009)
IDO and outcomes in ovarian cancer
Brad H. Nelson
GYNECOLOGIC ONCOLOGY (2009)
Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma
Tomoko Inaba et al.
GYNECOLOGIC ONCOLOGY (2009)
Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma
Sabine Schreck et al.
HEMATOLOGICAL ONCOLOGY (2009)
Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
Ethan M. Shevach
IMMUNITY (2009)
Galectin-3 regulates T-cell functions
Daniel K. Hsu et al.
IMMUNOLOGICAL REVIEWS (2009)
SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels
Ulrike Lorenz
IMMUNOLOGICAL REVIEWS (2009)
Phase I/II Trial of Tremelimumab in Patients With Metastatic Melanoma
Luis H. Camacho et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
Paul Salama et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Human Follicular Lymphoma CD39+-Infiltrating T Cells Contribute to Adenosine-Mediated T Cell Hyporesponsiveness
Shannon P. Hilchey et al.
JOURNAL OF IMMUNOLOGY (2009)
PD-1 Is a Regulator of NY-ESO-1-Specific CD8+ T Cell Expansion in Melanoma Patients
Julien Fourcade et al.
JOURNAL OF IMMUNOLOGY (2009)
Discovery of Potent Competitive Inhibitors of Indoleamine 2,3-Dioxygenase with in Vivo Pharmacodynamic Activity and Efficacy in a Mouse Melanoma Model
Eddy W. Yue et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer
Yan-Fang Gao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Negative Immune Regulator Tim-3 Is Overexpressed on T Cells in Hepatitis C Virus Infection and Its Blockade Rescues Dysfunctional CD4+ and CD8+ T Cells
Lucy Golden-Mason et al.
JOURNAL OF VIROLOGY (2009)
CD3+cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study
Luigi Laghi et al.
LANCET ONCOLOGY (2009)
Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients
Pierre Vereecken et al.
MELANOMA RESEARCH (2009)
Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival
Dusan Bogunovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Synergistic Reversal of Intrahepatic HCV-Specific CD8 T Cell Exhaustion by Combined PD-1/CTLA-4 Blockade
Nobuhiro Nakamoto et al.
PLOS PATHOGENS (2009)
Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation
Gabriel A. Rabinovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer
Philipp Wagner et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Two opposite signaling outputs are driven by the KIR2DL1 receptor in human CD4+ T cells
Emmanuelle Fourmentraux-Neves et al.
BLOOD (2008)
Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines
Michael A. Morse et al.
BLOOD (2008)
Hypoxia-Adenosinergic Immunosuppression: Tumor Protection by T Regulatory Cells and Cancerous Tissue Hypoxia
Michail V. Sitkovsky et al.
CLINICAL CANCER RESEARCH (2008)
DNA damage detection and repair pathways - Recent advances with inhibitors of checkpoint kinases in cancer therapy
Susan Ashwell et al.
CLINICAL CANCER RESEARCH (2008)
Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies
Raanan Berger et al.
CLINICAL CANCER RESEARCH (2008)
Silencing of endogenous IL-10 in human dendritic cells leads to the generation of an improved CTL response against human melanoma associated antigenic epitope, MART-127-35
Arvind Chhabra et al.
CLINICAL IMMUNOLOGY (2008)
Dendritic cell vaccines in melanoma: From promise to proof?
W. J. Lesterhuis et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma
Marketa Tomsova et al.
GYNECOLOGIC ONCOLOGY (2008)
Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes
Nathalie Demotte et al.
IMMUNITY (2008)
Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression
Inge S. van Houdt et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways
Shuguang Bi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma
Ke Pan et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
Mark E. Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures
Marie-Caroline Dieu-Nosjean et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection
R. Brad Jones et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Vaccination of a melanoma patient with mature dendritic cells pulsed with MAGE-3 peptides triggers the activity of nonvaccine anti-tumor cells
Javier Carrasco et al.
JOURNAL OF IMMUNOLOGY (2008)
Functional consequences of interactions between-human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells
David B. Rosen et al.
JOURNAL OF IMMUNOLOGY (2008)
CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator
Guifang Cai et al.
NATURE IMMUNOLOGY (2008)
The determination of the levels of circulating galectin-1 and-3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy
Sven Saussez et al.
ORAL ONCOLOGY (2008)
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
F. Stephen Hodi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Adoptive transfer of Treg depleted autologous T cells in advanced renal cell carcinoma
Fiona C. Thistlethwaite et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities
Stefan Diermayr et al.
BLOOD (2008)
Inhibitory B7-family molecules in the tumour microenvironment
Weiping Zou et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Increase of CD4+CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma:: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+CD25+ T lymphocytes
S. Audia et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival
Richard W. Griffiths et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs
Raymond M. Wong et al.
INTERNATIONAL IMMUNOLOGY (2007)
Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors
Danieta Massi et al.
HUMAN PATHOLOGY (2007)
Vaccine therapy for melanoma: Current status and future directions
Alicia M. Terando et al.
VACCINE (2007)
Evaluation of tumour-infiltrating CD4+CD25+FOXP3+ regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases
V. Mourmouras et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cells
Udo Baron et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Galectin-1 mediated suppression of Epstein-Barr virus-specific T-cell immunity in classic Hodgkin lymphoma
Maher K. Gandhi et al.
BLOOD (2007)
The AP1-dependent secretion of galectin-1 by Reed - Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
Przemyslaw Juszczynski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1
Hector F. Valenzuela et al.
CANCER RESEARCH (2007)
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Srinivas Nagaraj et al.
NATURE MEDICINE (2007)
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
Qiang Gao et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase a type I signaling
Tatiana Raskovalova et al.
CANCER RESEARCH (2007)
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Metronomic cyclophosphamide regimen selectively depletes CD4+ CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
Francois Ghiringhelli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Karin Fischer et al.
BLOOD (2007)
Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes
C. Feder-Mengus et al.
BRITISH JOURNAL OF CANCER (2007)
Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation
Ken S. Lau et al.
CELL (2007)
Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma
Sameer A. Siddiqui et al.
CLINICAL CANCER RESEARCH (2007)
A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer
Eric J. Small et al.
CLINICAL CANCER RESEARCH (2007)
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma
Padmanee Sharma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma
Rebecca C. Taylor et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Galectin-1:: a key effector of regulation mediated by CD4+CD25+ T cells
Marina I. Garin et al.
BLOOD (2007)
Unique human tumor antigens: Immunobiology and use in clinical trials
Giorgio Parmiani et al.
JOURNAL OF IMMUNOLOGY (2007)
A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy
Deirdre O'Mahony et al.
CLINICAL CANCER RESEARCH (2007)
Strongly enhanced IL-10 production using stable galectin-1 homodimers
Judith van der Leij et al.
MOLECULAR IMMUNOLOGY (2007)
Defining the prognostic value for galectin-3 in cutaneous melanoma
P. Vereecken et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2007)
Tumor infiltrating FOXP3+ regulatory T-cells are associated with recurrence in pathologic stage INSCLC patients
Rebecca P. Petersen et al.
CANCER (2006)
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
Gaynor J. Bates et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
Paolo Serafini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma
Laura L. Kruper et al.
CANCER (2006)
Inhibition of human tumor-infiltrating lymphocyte effector functions by the homophilic carcinoembryonic cell adhesion molecule 1 interactions
Gal Markel et al.
JOURNAL OF IMMUNOLOGY (2006)
Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome
Abigail M. Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Tumor progression despite massive influx of activated CD8+ T cells in a patient with malignant melanoma ascites
Helena Harlin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Ex-Vivo analysis of CD8+ T cells infiltrating colorectal tumors identifies a major effector-memory subset with low perforin content
Sheng-Wei Ye et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2006)
Tumor infiltrating lymphocytes in seminoma lesions comprise clonally expanded cytotoxic T cells
Sine Reker Hadrup et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Activation of murine CD4+ and CD8+ T lymphocytes leads to dramatic remodeling of N-linked glycans
Elena M. Comelli et al.
JOURNAL OF IMMUNOLOGY (2006)
Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro
C Blank et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition
Michael S. von Bergwelt-Baildon et al.
BLOOD (2006)
Association of antigen-processing machinery and HLA antigen phenotype of melanoma cells with survival in American Joint Committee on Cancer stage III and IV melanoma patients
Andrea Anichini et al.
CANCER RESEARCH (2006)
Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma
Gerhard G. Grabenbauer et al.
CLINICAL CANCER RESEARCH (2006)
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
I Kryczek et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients
JBAG Haanen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions
MR Hussein et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Heterogeneity of T-cell clones infiltrating primary malignant melanomas
Amir S. Yazdi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Differential effects of the tryptophan metabolite 3-hydroxyanthranilic acid on the proliferation of human CD8+ T cells induced by TCR triggering or homeostatic cytokines
WP Weber et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death
BN Stillman et al.
JOURNAL OF IMMUNOLOGY (2006)
Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers
C Badoual et al.
CLINICAL CANCER RESEARCH (2006)
Prostaglandin E2 impairs CD4+ T cell activation by inhibition of Ick.: Implications in Hodgkin's lymphoma
JM Chemnitz et al.
CANCER RESEARCH (2006)
CEACAM1: contact-dependent control of immunity
Scott D. Gray-Owen et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Effector memory T cells, early metastasis, and survival in colorectal cancer
F Pagès et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells
N van Baren et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
C Zhu et al.
NATURE IMMUNOLOGY (2005)
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
J Dannull et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma
WHJ Kruit et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR
J Mrena et al.
CLINICAL CANCER RESEARCH (2005)
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells
L Gattinoni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
PC Rodriguez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells
V Vignard et al.
JOURNAL OF IMMUNOLOGY (2005)
The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase
F Piras et al.
CANCER (2005)
Analysis of multiple biomarkers, shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)
P Farinha et al.
BLOOD (2005)
A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells
D Chauhan et al.
CANCER RESEARCH (2005)
Immunomonitoring tumor-specific T cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome
IJM de Vries et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Regulation of immune responses by L- arginine metabolism
V Bronte et al.
NATURE REVIEWS IMMUNOLOGY (2005)
In situ sensory adaptation of tumor-infiltrating T lymphocytes to peptide-MHC levels elicits strong antitumor reactivity
G Dorothée et al.
JOURNAL OF IMMUNOLOGY (2005)
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers
V Bronte et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma
BC Sheu et al.
CANCER RESEARCH (2005)
Expression of galectin-3 in primary and metastatic melanoma: immunohistochemical studies on human lesions and nude mice xenograft tumors
P Vereecken et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2005)
High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens
C Germeau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen
C Lurquin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Recent advances in tumour antigen-specific therapy:: In vivo veritas
YD Mahnke et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator
JR Sedy et al.
NATURE IMMUNOLOGY (2005)
Effector function of human tumor-specific CD8 T cells in melanoma lesions:: A state of local functional tolerance
A Zippelius et al.
CANCER RESEARCH (2004)
Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas
JJF Muris et al.
LEUKEMIA (2004)
Expression of granzyme B in viral hepatitis in patients with ALPS
N André et al.
HEPATOLOGY (2004)
Presentation of galectin-1 by extracellular matrix triggers T cell death
JL He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma
A Ladányi et al.
CLINICAL CANCER RESEARCH (2004)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus
N Koide et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Cell surface overexpression of galectin-3 and the presence of its ligand 90k in the blood plasma as determinants in colon neoplastic lesions
C Greco et al.
GLYCOBIOLOGY (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function
MN Ince et al.
IMMUNOLOGY (2004)
SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation
JM Chemnitz et al.
JOURNAL OF IMMUNOLOGY (2004)
Nucleocytoplasmic lectins
JL Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2004)
Prognostic role of CD8+tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability
F Prall et al.
HUMAN PATHOLOGY (2004)
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
SS Dave et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma:: possible association with suppression of micrometastasis
T Chiba et al.
BRITISH JOURNAL OF CANCER (2004)
Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen
C Lonchay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2
WB Ma et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?
G Gasparini et al.
LANCET ONCOLOGY (2003)
Differential expression of perforin and granzyme B in the liver of patients with chronic hepatitis C
BN Pham et al.
HUMAN PATHOLOGY (2003)
Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G
M Shiroishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
GQ Phan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients
ME Dudley et al.
JOURNAL OF IMMUNOTHERAPY (2003)
Galectin-1-mediated apoptosis in mycosis fungoides: The roles of CD7 and cell surface glycosylation
AA Roberts et al.
MODERN PATHOLOGY (2003)
CD5 inhibits signaling at the immunological synapse without impairing its formation
U Brossard et al.
JOURNAL OF IMMUNOLOGY (2003)
Tolerance, DCs and tryptophan: much ado about IDO
U Grohmann et al.
TRENDS IN IMMUNOLOGY (2003)
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
TJ Curiel et al.
NATURE MEDICINE (2003)
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
FS Hodi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy
N Selenko-Gebauer et al.
JOURNAL OF IMMUNOLOGY (2003)
Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway
Y Kashio et al.
JOURNAL OF IMMUNOLOGY (2003)
The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death
M Amano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Ex vivo identification, isolation and analysis of tumor-cytolytic T cells
V Rubio et al.
NATURE MEDICINE (2003)
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells
CL Slingluff et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study
BW Guess et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2003)
Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma
B Dréno et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
ME Dudley et al.
SCIENCE (2002)
Tumor-specific shared antigenic peptides recognized by human T cells
P van der Bruggen et al.
IMMUNOLOGICAL REVIEWS (2002)
Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen
PG Coulie et al.
IMMUNOLOGICAL REVIEWS (2002)
Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells:: Mediation of suppression by tryptophan metabolites
P Terness et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance
T Kageshita et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Regulation of T cell receptor CD3 chain expression by L-arginine
PC Rodriguez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria -: A role for synexin in galectin-3 translocation
F Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Activated status of tumour-infiltrating lymphocytes and apoptosis in testicular seminoma
E Yakirevich et al.
JOURNAL OF PATHOLOGY (2002)
Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells
D Saverino et al.
JOURNAL OF IMMUNOLOGY (2002)
Expression of galectins in cancer: A critical review
F van den Brule et al.
GLYCOCONJUGATE JOURNAL (2002)
Galectin-9 in physiological and pathological conditions
M Hirashima et al.
GLYCOCONJUGATE JOURNAL (2002)
Biochemotherapy of metastatic malignant melanoma.: Predictive value of tumour-infiltrating lymphocytes
A Håkansson et al.
BRITISH JOURNAL OF CANCER (2001)
CD45 modulates galectin-1-induced T cell death:: Regulation by expression of core 2 O-glycans
JT Nguyen et al.
JOURNAL OF IMMUNOLOGY (2001)
A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3
PG Coulie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Prognostic significance of tumour-infiltrating T lymphocytes and T-cell subsets in de novo diffuse large B-cell lymphoma:: a multiparameter flow cytometry study
Y Xu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer
AD Santin et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2001)
Accelerated growth signals and low tumor-infiltrating lymphocyte levels predict poor outcome in T4 esophageal squamous cell carcinoma
M Yasunaga et al.
ANNALS OF THORACIC SURGERY (2000)
Tumour necrosis factor-α and transforming growth factor-β are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization
L. Boldrini et al.
BRITISH JOURNAL OF CANCER (2000)
Tetramer-guided analysis of TCR β-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients
D Valmori et al.
JOURNAL OF IMMUNOLOGY (2000)
Mechanisms of disease:: Role of transforming growth factor β in human disease.
GC Blobe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells
H Walzel et al.
GLYCOBIOLOGY (2000)
Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3(+) tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis
B Melichar et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
分享论文
